Utilizing cascading stage of SIRs (CSIRs), a miniaturized sext‐band bandpass filter is investigated and fabricated. Purposely, two‐section SIRs with high/low impedance‐ratio are built up for not only enough spurious frequency for sext‐band application, but excellent control on these frequencies. In addition, architecture of CSIR, namely number and arrangement of employed SIRs, is optimized for widening potential frequency range with good response in each passband. Meanwhile, on account of transversal signal interaction concept together with mixed electric magnetic coupling of CSIRI,II, transmission zeros (TZs) and transmission poles (TPs) can be excited alternately. Since coupling is introduced by embedding CSIRs without adding any other structures, configuration of proposed design is compact. Moreover, tapped position of 0° feeding branch can be adjusted for improving filter performance. Therefore, design of miniaturized sext‐band bandpass filter becomes available. Good agreement between simulated and measured results validates the design method.

No abstract

No abstract

The effects of finite temporal duration on the spatial solitons in a planar optical waveguide are analyzed. The results show that (i) the self-trapped pulses with finite temporal duration are unstable and collapse at higher peak power in a planar optical waveguide with the anomalous group velocity dispersion (GVD), but the collapse does not occur in a planar optical waveguide with the normal GVD; (ii) the spatial soliton with finite temporal duration has a transverse velocity which is proportional to the spatial width and inversely proportional to the temporal duration of the soliton, and the bright spatiotemporal solitons do not form multiple soliton bound states; and (iii) the peak power required for self-trapping of the pulse in a planar optical waveguide with the normal GVD is less than the critical peak power for collapse of the pulses in a planar optical waveguide with the anomalous GVD.

Analysis of anti-drug antibodies (ADAs) is important for risk assessment in clinical trials. ADA detection can be very difficult in the presence of high circulating levels of drug or target...